|1|Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment. (22777929)
Vos J.... Tibben A.
|2|Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases. (23935836)
Blanco A.... Vega A.
|3|Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists. (24021253)
Meaney-Delman D.... Bellcross C.A.
|4|Unpacking the blockers: understanding perceptions and social constraints of health communication in hereditary breast ovarian cancer (HBOC) susceptibility families. (21547418)
Peters J.A.... Greene M.H.
|5|Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia. (21203900)
Konecny M.... Bartosova Z.
|6|Hereditary breast-ovarian cancer syndrome in Russia. (22649661)
Sokolenko A.P.... Imyanitov E.N.
|7|Coronary heart disease risk profile in women who underwent salpingo-oophorectomy to prevent hereditary breast ovarian cancer. (20169665)
Michelsen T.M.... rum A.
|8|Hereditary breast ovarian cancer syndromes in the Maritimes. (20181317)
O'Quinn C.... Kieser K.
|9|Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control. (23199084)
|10|Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study. (19008092)
Michelsen T.M.... rum A.
|11|The prevalence of hereditary breast/ovarian cancer risk in patients with a history of breast or ovarian cancer in Japanese subjects. (20149041)
Komata D.... Tanaka K.
|12|Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS). (18385162)
Peshkin B.N.... Tercyak K.P.
|13|A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer. (19178933)
Michelsen T.M.... Dahl A.A.
|14|Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer. (19820364)
Michelsen T.M.... Dahl A.A.
|15|Founder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany, Central Italy. (18821011)
Papi L.... Genuardi M.
|16|BRCA1 and BRCA2 risk perceptions among African American women at increased risk for hereditary breast-ovarian cancer. (18417966)
Kessler L.... Halbert C.H.
|17|Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer. (19016756)
Sugano K.... Miki Y.
|18|Hereditary breast/ovarian cancer: clinicopathological characteristics and survival of BRCA2 positive and negative cases. (19066131)
Syamala V.... Ankathil R.
|19|Psychological and cancer-specific distress at 18 months post-testing in women with demonstrated BRCA1 mutations for hereditary breast/ovarian cancer. (18219587)
Reichelt J.G.... Dahl A.A.
|20|Hereditary breast-ovarian cancer: clinical findings and medical management. (17901820)
Marshall M.... Solomon S.
|21|A novel BRCA1 mutation in an Indian family with hereditary breast/ovarian cancer. (17131039)
Gajalakshmi P.... Thangaraj K.
|22|Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. (16527602)
Lynch H.T.... Gong G.
|23|Germline mutations of BRCA1 in two Korean hereditary breast/ovarian cancer families. (16465413)
Kim T.J.... Kim B.G.
|24|Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer. (16980814)
Halbert C.H.... Wileyto E.P.
|25|Clinical, molecular and geographical features of hereditary breast/ovarian cancer in latvia. (20223033)
Gardovskis A.... Gardovskis J.
|26|Hereditary Breast-Ovarian Cancer Team of the University Medical Centre Groningen (UMCG) - a Report. (20223045)
Mourits M.J.... de Vries J.
|27|Re: "Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations". (16188301)
Olivier R.I.... van Beurden M.
|28|Surveillance behavior and prophylactic surgery after predictive testing for hereditary breast/ovarian cancer. (16252621)
Claes E.... Legius E.
|29|The effect of experiential knowledge on construction of risk perception in hereditary breast/ovarian cancer. (15789156)
|30|Prevalence of five previously reported and recurrent BRCA1 genetic rearrangement mutations in 20,000 patients from hereditary breast/ovarian cancer families. (15846789)
Hendrickson B.C.... Scholl T.
|31|Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations. (15863145)
Casey M.J.... Lynch H.T.
|32|Advocate's Viewpoint on Hereditary Breast/Ovarian Cancer. (20233464)
|33|Carrier risk status changes resulting from mutation testing in hereditary non-polyposis colorectal cancer and hereditary breast-ovarian cancer. (12920070)
Watson P.... Lynch H.T.
|34|Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist. (12586815)
Lynch H.T.... Rubinstein W.S.
|35|Contribution of BRCA2 germline mutations to hereditary breast/ovarian cancer in Germany. (11897832)
Hamann U.... Scott R.J.
|36|Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information. (12210341)
DiCastro M.... Friedman E.
|37|Hereditary breast/ovarian cancer--pitfalls in genetic counseling. (11683778)
Dagan E.... Gershoni-Baruch R.
|38|Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing. (11464240)
Lodder L.... Niermeijer M.F.
|39|Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds. (10985881)
Casey M.J.... Watson P.
|40|Physicians' attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines. (10780786)
Julian-Reynier C.... Sobol H.
|41|Congress report of the Sixth International Meeting on Psychosocial Aspects of Hereditary Breast/Ovarian Cancer Genetic Testing. (11180590)
Julian-Reynier C.... Watson M.
|42|Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer. (10502438)
Meiser B.... Tucker K.
|43|Acceptable strategies for dealing with hereditary breast/ovarian cancer risk. (9168189)
Eisinger F.... Sobol H.
|44|German family study on hereditary breast-ovarian cancer. (8863152)
Hamann U.... Chang-Claude J.
|45|BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. (8648868)
Lerman C.... Lynch H.
|46|Insurance adjudication favoring prophylactic surgery in hereditary breast-ovarian cancer syndrome. (7705697)
Lynch H.T.... Lynch J.
|47|Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer. (8302608)
Jolly K.W.... Look A.T.
|48|The human insulin-like growth factor-binding protein 4 gene maps to chromosome region 17q12-q21.1 and is close to the gene for hereditary breast-ovarian cancer. (7507078)
Tonin P.... Huynh H.
|49|Hereditary breast-ovarian cancer: how can we use the new DNA markers to improve patient management? (8306541)
|50|Genetic counselling and hereditary breast ovarian cancer. (1349410)
Lynch H.T.... Watson P.